About   Help   FAQ
Phenotypes associated with this allele
Allele Symbol
Allele Name
Allele ID
Tacc3tm1.1Tno
targeted mutation 1.1, Tetsuo Noda
MGI:3763220
Summary 5 genotypes
Jump to Allelic Composition Genetic Background Genotype ID
hm1
Tacc3tm1.1Tno/Tacc3tm1.1Tno involves: C57BL/6 MGI:3763273
ht2
Tacc3tm1.1Tno/Tacc3tm1.2Tno involves: C57BL/6 MGI:3763271
cn3
Tacc3tm1.1Tno/Tacc3tm1.2Tno involves: C57BL/6 MGI:3763272
cn4
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Tacc3tm1.1Tno/Tacc3tm1.2Tno
Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 MGI:5305073
cn5
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Tacc3tm1.1Tno/Tacc3+
Trp53tm1Tyj/Trp53tm1Tyj
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6 MGI:5305074


Genotype
MGI:3763273
hm1
Allelic
Composition
Tacc3tm1.1Tno/Tacc3tm1.1Tno
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tacc3tm1.1Tno mutation (0 available); any Tacc3 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are born at Mendelian ratios and no overt abnormalities are detected




Genotype
MGI:3763271
ht2
Allelic
Composition
Tacc3tm1.1Tno/Tacc3tm1.2Tno
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tacc3tm1.1Tno mutation (0 available); any Tacc3 mutation (29 available)
Tacc3tm1.2Tno mutation (0 available); any Tacc3 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
normal phenotype
• mice are born at Mendelian ratios and no overt abnormalities are detected




Genotype
MGI:3763272
cn3
Allelic
Composition
Tacc3tm1.1Tno/Tacc3tm1.2Tno
Genetic
Background
involves: C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Tacc3tm1.1Tno mutation (0 available); any Tacc3 mutation (29 available)
Tacc3tm1.2Tno mutation (0 available); any Tacc3 mutation (29 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
cellular
• 36% of mouse embryonic fibroblasts (MEFs) transfected with an adenovirus cre vector exhibit abnormal mitosis similar to in Tacc3tm1Tno MEFs and produce binucleated cells, 7.8% of cells produce 3 or 4 cells after cytokinesis and 22% of cells fail to separate sister chromatids
• however, 37% of transfected MEFs complete mitosis normally




Genotype
MGI:5305073
cn4
Allelic
Composition
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Tacc3tm1.1Tno/Tacc3tm1.2Tno
Trp53tm1Tyj/Trp53tm1Tyj
Genetic
Background
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(cre/ERT2)Tyj mutation (3 available); any Gt(ROSA)26Sor mutation (992 available)
Tacc3tm1.1Tno mutation (0 available); any Tacc3 mutation (29 available)
Tacc3tm1.2Tno mutation (0 available); any Tacc3 mutation (29 available)
Trp53tm1Tyj mutation (12 available); any Trp53 mutation (239 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• in the absence of 4OHT, mutants develop thymic lymphoma tumors
• administration of 4-hydroxytamoxifen (4OHT) to induce Cre recombination results in regression of autochthonous thymic lymphoma, with a reduction in tumor volume to 96% and 26% of original volume, over 3 and 10 days, respectively
• regression of tumors is due to apoptosis in thymic lymphoma
• 4OHT treatment of mutants results in massive apoptosis in thymic lymphomas but not in normal thymic tissue or other tissues
• lymphoma cells contain multi-polar spindles, indicating aberrant spindle formation, resulting in mitotic arrest and rapid cell death

endocrine/exocrine glands
• in the absence of 4OHT, mutants develop thymic lymphoma tumors

immune system
• in the absence of 4OHT, mutants develop thymic lymphoma tumors

hematopoietic system
• in the absence of 4OHT, mutants develop thymic lymphoma tumors




Genotype
MGI:5305074
cn5
Allelic
Composition
Gt(ROSA)26Sortm1(cre/ERT2)Tyj/Gt(ROSA)26Sor+
Tacc3tm1.1Tno/Tacc3+
Trp53tm1Tyj/Trp53tm1Tyj
Genetic
Background
involves: 129S2/SvPas * 129S4/SvJae * C57BL/6
Find Mice Using the International Mouse Strain Resource (IMSR)
Mouse lines carrying:
Gt(ROSA)26Sortm1(cre/ERT2)Tyj mutation (3 available); any Gt(ROSA)26Sor mutation (992 available)
Tacc3tm1.1Tno mutation (0 available); any Tacc3 mutation (29 available)
Trp53tm1Tyj mutation (12 available); any Trp53 mutation (239 available)
phenotype observed in females
phenotype observed in males
N normal phenotype
neoplasm
• administration of 4-hydroxytamoxifen (4OHT) to induce Cre recombination results in a rapid increase in tumor volume

endocrine/exocrine glands
• administration of 4-hydroxytamoxifen (4OHT) to induce Cre recombination results in a rapid increase in tumor volume

hematopoietic system
• administration of 4-hydroxytamoxifen (4OHT) to induce Cre recombination results in a rapid increase in tumor volume

immune system
• administration of 4-hydroxytamoxifen (4OHT) to induce Cre recombination results in a rapid increase in tumor volume





Contributing Projects:
Mouse Genome Database (MGD), Gene Expression Database (GXD), Mouse Models of Human Cancer database (MMHCdb) (formerly Mouse Tumor Biology (MTB)), Gene Ontology (GO)
Citing These Resources
Funding Information
Warranty Disclaimer, Privacy Notice, Licensing, & Copyright
Send questions and comments to User Support.
last database update
10/29/2024
MGI 6.24
The Jackson Laboratory